A citation-based method for searching scientific literature

Gale Smith, Ye Liu, David Flyer, Michael J Massare, Bin Zhou, Nita Patel, Larry Ellingsworth, Maggie Lewis, James F Cummings, Greg Glenn. Vaccine 2017
Times Cited: 28







List of co-cited articles
266 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies.
Masaru Kanekiyo, Chih-Jen Wei, Hadi M Yassine, Patrick M McTamney, Jeffrey C Boyington, James R R Whittle, Srinivas S Rao, Wing-Pui Kong, Lingshu Wang, Gary J Nabel. Nature 2013
475
28

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Seth J Zost, Kaela Parkhouse, Megan E Gumina, Kangchon Kim, Sebastian Diaz Perez, Patrick C Wilson, John J Treanor, Andrea J Sant, Sarah Cobey, Scott E Hensley. Proc Natl Acad Sci U S A 2017
328
28

Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
Vivek Shinde, Louis Fries, Yukun Wu, Sapeckshita Agrawal, Iksung Cho, D Nigel Thomas, Michelle Spindler, Elizabeth Lindner, Timothy Hahn, Joyce Plested,[...]. N Engl J Med 2018
26
30

Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine.
Catharine I Paules, Sheena G Sullivan, Kanta Subbarao, Anthony S Fauci. N Engl J Med 2018
146
25

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, Suzana Sabaiduc, Alireza Eshaghi, James A Dickinson, Kevin Fonseca, Anne-Luise Winter, Jonathan B Gubbay, Mel Krajden,[...]. PLoS One 2014
299
25

Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine.
Jacob Atsmon, Efrat Kate-Ilovitz, Dimitry Shaikevich, Yossi Singer, Inna Volokhov, Kirsten Y Haim, Tamar Ben-Yedidia. J Clin Immunol 2012
100
25

Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial.
Olga Pleguezuelos, Stuart Robinson, Gregory A Stoloff, Wilson Caparrós-Wanderley. Vaccine 2012
63
21

A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.
Olga Pleguezuelos, Stuart Robinson, Ana Fernández, Gregory A Stoloff, Alex Mann, Anthony Gilbert, Ganesh Balaratnam, Tom Wilkinson, Rob Lambkin-Williams, John Oxford,[...]. Clin Vaccine Immunol 2015
51
21

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.
Hadi M Yassine, Jeffrey C Boyington, Patrick M McTamney, Chih-Jen Wei, Masaru Kanekiyo, Wing-Pui Kong, John R Gallagher, Lingshu Wang, Yi Zhang, M Gordon Joyce,[...]. Nat Med 2015
432
21

Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
Jian Yan, Matthew P Morrow, Jaemi S Chu, Trina Racine, Charles C Reed, Amir S Khan, Kate E Broderick, J Joseph Kim, Gary P Kobinger, Niranjan Y Sardesai,[...]. Vaccine 2018
15
33

ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.
Karin Lövgren Bengtsson, Bror Morein, Albert Dme Osterhaus. Expert Rev Vaccines 2011
93
17

Epitope-based approaches to a universal influenza vaccine.
Tanya Gottlieb, Tamar Ben-Yedidia. J Autoimmun 2014
32
17

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
Nicholas C Wu, Seth J Zost, Andrew J Thompson, David Oyen, Corwin M Nycholat, Ryan McBride, James C Paulson, Scott E Hensley, Ian A Wilson. PLoS Pathog 2017
149
17

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA.
Alyse D Portnoff, Nita Patel, Michael J Massare, Haixia Zhou, Jing-Hui Tian, Bin Zhou, Vivek Shinde, Gregory M Glenn, Gale Smith. Vaccines (Basel) 2020
15
33

Quadrivalent influenza nanoparticle vaccines induce broad protection.
Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A Gillespie, Geoffrey B Hutchinson, Young-Jun Park, Syed M Moin, Oliver J Acton, Rashmi Ravichandran, Mike Murphy, Deleah Pettie,[...]. Nature 2021
80
17


Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
Carlos A DiazGranados, Andrew J Dunning, Murray Kimmel, Daniel Kirby, John Treanor, Avi Collins, Richard Pollak, Janet Christoff, John Earl, Victoria Landolfi,[...]. N Engl J Med 2014
475
14

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.
A Danielle Iuliano, Katherine M Roguski, Howard H Chang, David J Muscatello, Rakhee Palekar, Stefano Tempia, Cheryl Cohen, Jon Michael Gran, Dena Schanzer, Benjamin J Cowling,[...]. Lancet 2018
14


Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population.
Jacob Atsmon, Yoseph Caraco, Sagit Ziv-Sefer, Dimitry Shaikevich, Ester Abramov, Inna Volokhov, Svetlana Bruzil, Kirsten Y Haima, Tanya Gottlieb, Tamar Ben-Yedidia. Vaccine 2014
61
14

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
Emily J Erbelding, Diane J Post, Erik J Stemmy, Paul C Roberts, Alison Deckhut Augustine, Stacy Ferguson, Catharine I Paules, Barney S Graham, Anthony S Fauci. J Infect Dis 2018
249
14

Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
Charles B Stauft, Chen Yang, J Robert Coleman, David Boltz, Chiahsuan Chin, Anna Kushnir, Steffen Mueller. PLoS One 2019
16
25


A Synthetic Micro-Consensus DNA Vaccine Generates Comprehensive Influenza A H3N2 Immunity and Protects Mice Against Lethal Challenge by Multiple H3N2 Viruses.
Sarah T C Elliott, Amelia A Keaton, Jacqueline D Chu, Charles C Reed, Bradley Garman, Ami Patel, Jian Yan, Kate E Broderick, David B Weiner. Hum Gene Ther 2018
10
40

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.
Raffael Nachbagauer, Wen-Chun Liu, Angela Choi, Teddy John Wohlbold, Talia Atlas, Madhusudan Rajendran, Alicia Solórzano, Francesco Berlanda-Scorza, Adolfo García-Sastre, Peter Palese,[...]. NPJ Vaccines 2017
91
14

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.
Florian Krammer, Natalie Pica, Rong Hai, Irina Margine, Peter Palese. J Virol 2013
297
14

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.
Tom M Wilkinson, Chris K F Li, Cecilia S C Chui, Arthur K Y Huang, Molly Perkins, Julia C Liebner, Rob Lambkin-Williams, Anthony Gilbert, John Oxford, Ben Nicholas,[...]. Nat Med 2012
695
14

A highly conserved neutralizing epitope on group 2 influenza A viruses.
Damian C Ekiert, Robert H E Friesen, Gira Bhabha, Ted Kwaks, Mandy Jongeneelen, Wenli Yu, Carla Ophorst, Freek Cox, Hans J W M Korse, Boerries Brandenburg,[...]. Science 2011
631
14

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.
Christine B Turley, Richard E Rupp, Casey Johnson, David N Taylor, Julie Wolfson, Lynda Tussey, Uma Kavita, Lawrence Stanberry, Alan Shaw. Vaccine 2011
218
14

Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season.
Melissa A Rolfes, Brendan Flannery, Jessie R Chung, Alissa O'Halloran, Shikha Garg, Edward A Belongia, Manjusha Gaglani, Richard K Zimmerman, Michael L Jackson, Arnold S Monto,[...]. Clin Infect Dis 2019
163
14

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
Cheryl Keech, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou,[...]. N Engl J Med 2020
682
14

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Karin Lövgren Bengtsson, Haifeng Song, Linda Stertman, Ye Liu, David C Flyer, Michael J Massare, Ren-Huan Xu, Bin Zhou, Hanxin Lu, Steve A Kwilas,[...]. Vaccine 2016
69
14

The biology of influenza viruses.
Nicole M Bouvier, Peter Palese. Vaccine 2008
565
14

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
Richard D Antrobus, Lynda Coughlan, Tamara K Berthoud, Matthew D Dicks, Adrian Vs Hill, Teresa Lambe, Sarah C Gilbert. Mol Ther 2014
141
14

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults.
L Coughlan, S Sridhar, R Payne, M Edmans, A Milicic, N Venkatraman, B Lugonja, L Clifton, C Qi, P M Folegatti,[...]. EBioMedicine 2018
85
14

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, David I Bernstein, Jeffrey Guptill, Emmanuel B Walter, Franceso Berlanda-Scorza, Daniel Stadlbauer, Patrick C Wilson, Teresa Aydillo,[...]. Nat Med 2021
108
14

The 2015 global production capacity of seasonal and pandemic influenza vaccine.
Kenneth A McLean, Shoshanna Goldin, Claudia Nannei, Erin Sparrow, Guido Torelli. Vaccine 2016
52
10


Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
Barry Buckland, Robert Boulanger, Mireli Fino, Indresh Srivastava, Kathy Holtz, Nikolai Khramtsov, Clifton McPherson, Jamal Meghrous, Paul Kubera, Manon M J Cox. Vaccine 2014
49
10

Influenza Virus: Dealing with a Drifting and Shifting Pathogen.
Hyunsuh Kim, Robert G Webster, Richard J Webby. Viral Immunol 2018
134
10

Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs.
Linda Widjaja, Natalia Ilyushina, Robert G Webster, Richard J Webby. Virology 2006
62
10

Current and next generation influenza vaccines: Formulation and production strategies.
Peter C Soema, Ronald Kompier, Jean-Pierre Amorij, Gideon F A Kersten. Eur J Pharm Biopharm 2015
171
10

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.
Julie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, Ingelise J Gordon, Mary E Enama, Cynthia S Hendel, Patrick M McTamney, Melissa B Pearce, Hadi M Yassine, Jeffrey C Boyington,[...]. Lancet Infect Dis 2011
159
10

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.
Manon M J Cox, Ruvim Izikson, Penny Post, Lisa Dunkle. Ther Adv Vaccines 2015
72
10

Traditional and new influenza vaccines.
Sook-San Wong, Richard J Webby. Clin Microbiol Rev 2013
203
10

A fast track influenza virus vaccine produced in insect cells.
Manon M J Cox, Yoshifumi Hashimoto. J Invertebr Pathol 2011
74
10

Towards an understanding of the adjuvant action of aluminium.
Philippa Marrack, Amy S McKee, Michael W Munks. Nat Rev Immunol 2009
533
10

Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
Jagadish Hiremath, Kyung-il Kang, Ming Xia, Mohamed Elaish, Basavaraj Binjawadagi, Kang Ouyang, Santosh Dhakal, Jesus Arcos, Jordi B Torrelles, X Jiang,[...]. PLoS One 2016
48
10

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
Daniel F Hoft, Elizabeth Babusis, Shewangizaw Worku, Charles T Spencer, Kathleen Lottenbach, Steven M Truscott, Getahun Abate, Isaac G Sakala, Kathryn M Edwards, C Buddy Creech,[...]. J Infect Dis 2011
226
10

Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice.
Chen Yang, Steven Skiena, Bruce Futcher, Steffen Mueller, Eckard Wimmer. Proc Natl Acad Sci U S A 2013
79
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.